Frank D. Lee - Feb 28, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role: President and CEO, Director
Signature: /s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol: FMTX
Transactions as of: Feb 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/2/2022, 04:17 PM
Previous filing: Feb 25, 2022
Next filing: Mar 28, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FMTX	Common Stock	Award	$0	+122K	+152.52%	$0.00	201K	Feb 28, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FMTX	Stock Option (Right to Buy)	Award	$0	+183K		$0.00	183K	Feb 28, 2022	Common Stock	183K	$9.86	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2	25% of the shares subject to the stock option shall vest on February 28, 2023, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.